On July 7, 2025, Morgan Stanley released an updated analysis on RXO, providing key insights into the stock's performance outlook. Notably, analyst Ravi Shanker has maintained his current rating on RXO, keeping it at "Equal-Weight". This indicates a neutral stance, suggesting that the stock is expected to perform in line with the broader market or its peers.
In addition to maintaining the rating, Morgan Stanley made a significant adjustment to the price target for RXO. The price target has been lowered from the previous figure of USD 23.00 to a new level of USD 21.00. This adjustment reflects a decrease of approximately 8.70%.
Investors and market analysts often closely monitor changes in price targets and ratings from major financial institutions like Morgan Stanley, as these can provide important signals regarding expected stock performance. With RXO's revised price target, stakeholders will be considering the implications for future investment decisions.
Despite the lowered price target, the retention of the "Equal-Weight" rating suggests that Morgan Stanley does not foresee a significant divergence in RXO's performance relative to the market at this time.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 17 analysts, the average target price for RXO Inc (RXO, Financial) is $16.47 with a high estimate of $21.00 and a low estimate of $11.00. The average target implies an downside of 0.18% from the current price of $16.50. More detailed estimate data can be found on the RXO Inc (RXO) Forecast page.
Based on the consensus recommendation from 21 brokerage firms, RXO Inc's (RXO, Financial) average brokerage recommendation is currently 2.9, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for RXO Inc (RXO, Financial) in one year is $22.21, suggesting a upside of 34.61% from the current price of $16.5. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the RXO Inc (RXO) Summary page.
